Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection

Gut

Volumn 46, Issue 2, 2000, Pages 260-269

  McGuinness, P H ^a   Painter, D ^a   Davies, S ^a   McCaughan, G W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cytokine; Hepatitis C; Interleukin; MAC387; Macrophage

Indexed keywords

CD68 ANTIGEN; CYTOKINE; INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MACROPHAGE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-18; INTERLEUKIN-6; LIVER; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034121558     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.2.260     Document Type: Article

References (65)

1. 1 Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992;327:1899 905.
2. 2 Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969 74.
3. 3 Seeff LB. Natural history of viral hepatitis, type C. Semin Gastrointest Dis 1995;6:20-7.
4. 4 Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
5. 5 Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63.
6. 6 Mita E, Hayashi N, Kanazawa Y, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994;21:468-73.
7. 7 McGuinness PH, Bishop GA, Painter DM, et al. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996;23:676-87.
8. 8 Nakagawa H, Shimomura H, Hasui T, et al. Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction. Dig Dis Sci 1994;39:225-33.
9. 9 Sakamoto N, Enomoto N, Kurosaki M, et al. Detection and quantification of hepatitis C virus RNA replication in the liver. J Hepatol 1994;20:593-7.
10. 10 Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-9.
11. 11 Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995;22:30-5.
12. 12 Zeuzem S, Schmidt JM, Lee JH, et al. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 1996;23:366-71.
13. 13 Cooper S, Kowalski H, Erickson AL, et al. The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class 1 allotypes from two chimpanzee species. J Exp Med 1996;183:663-8.
14. 14 Pasi KJ, Evans JA, Wadhwa M, et al. Association of changes in monocyte antigen presentation and cytokine production in haemophilic boys with treatment and blood-borne virus infection. Br J Haematol 1995;91:191-6.
15. 15 Bertoletti A, Delios MM, Boni C, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997;112: 193-9.
16. 16 Dumoulin FL, Bach A, Leifeld L, et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997;175:681-5.
17. 17 Koziel MJ. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 1997;4:31-41.
18. 18 Simmonds P, Rose KA, Graham S, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993;31:1493-503.
19. 19 Gabrielli A, Zhang ZX, Cherubini G, et al. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol 1996; 105:59-64.
20. 20 Bansal AS, Bruce J, Hogan PG, et al. Serum soluble CD23 but not IL18, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection. Clin Immunol Immunopathol 1997;84:139-44.
21. 21 Minutello MA, Pileri P, Unutmaz D, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:17-25.
22. 22 Spengler U, Lechmann M, Irrgang B, et al. Immune responses in hepatitis C virus infection. J Hepatol 1996;24: 20-5.
23. 23 Napoli J, Bishop GA, McGuinness PH, et al. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24:759-65.
24. 24 McCaughan GW, Napoli J, McGuinness P, et al. T1 vs T2 cytokine responses in chronic HCV: implications for mechanisms of liver injury. Viral Hepatitis Reviews 1997;3: 129-42.
25. 25 Khakoo SI, Soni PN, Savage K, et al. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am J Pathol 1997;150: 963-70.
26. 26 Gaweco AS, Rustgi V, Hassanein T, et al. Defective antiviral cytokines in chronic hepatitis C virus infected livers [abstract]. Hepatology 1995;22:335A.
27. 27 Dumoulin FL, Honecker T, Sauerbruch T, et al. Decreased intrahepatic IL-1β and TNFu mRNA levels in chronic hepatitis C: clues to impaired function of mononuclear phagocyte system in chronic hepatitis C [abstract]. IX Triennial International Symposium on Viral Hepatitis and Liver Disease, Rome, 1996:174A.
28. 28 Marrogi AJ, Cheles MK, Gerber MA. Chronic hepatitis C. Analysis of host immune response by immunochemistry. Arch Pathol Lab Med 1995;119:232-7.
29. 29 Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-8.
30. 30 Garcia-Monzon C, Garcia-Bluey L, Borque MJ, et al. Phenotypic and functional characterization of intrahepatic natural killer and macrophages in viral chronic hepatitis C (VCH) [abstract]. Hepatology 1995;22:337A.
31. 31 Garcia-Monzon C, Garcia-Iglesias C, Garcia-Bluey L, et al. Phenotypic and functional characterisation of intrahepatic natural killer cells and macrophages in viral chronic hepatitis [abstract]. International Meeting on Hepatitis C Virus and Related Viruses: Molecular Virology and Pathogenesis, Venenzia-Lido, Italy, 1998:P232.
32. 32 Yamamoto K, Ohmoto M, Matsumoto S, et al. Activated liver macrophages in human liver diseases. J Gastroenterol Hepatol 1995;10:S72-6.
33. 33 Leicester KL, Olynyk JK, Fox ES, et al. CD14-positive macrophages/monocytes in hepatitis C injury [abstract). J Gastroenterol Hepatol 1997;12(suppl):A30.
34. 34 Rutherford MS, Witsell A, Schook LB. Mechanisms generating functionally heterogenous macrophages: chaos revisted. J Leukoc Biol 1993;53:602-18.
35. 35 Tomita M, Yamamoto K, Kobashi H, et al. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology 1994;20:317-25.
36. 36 Tomita M, Yamamoto K, Kobashi H, et al. Immunohistochemical analysis on the expressions of maturation associated antigens, Fc-gamma receptors and CD14 in normal and diseased human liver macrophages. International Hepatology Communications 1994;2:245-9.
37. 37 Davey FR, Gatter KC, Ralfkiaer E, et al. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues. Am J Pathol 1987;129: 54-63.
38. 38 Flavell DJ, Jones DB, Wright DH. Identification of tissue histocytes on paraffin sections by a new monoclonal antibody. J Histocchem Cytochem 1987,35:1217-26.
39. 39 Brandtzaeg P, Jones DB, Flavell DJ, et al. MAC387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J Clin Pathol 1988;41:963-70.
40. 40 Pulford KAF, Rigney EM, Micklem KJ, et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42:414-21.
41. 41 Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am J Clin Pathol 1987;87:681-99.
42. 42 Bardadin KA, Scheuer PJ, Peczek A, et al. Immunocytochemical observations on macrophage populations in normal fetal and adult human liver. J Pathol 1991;164:253-9.
43. 43 van den Oord JJ, De Vos R, Facchetti F, et al. Distribution of non-lymphoid, inflammatory cells in chronic HBV infection. J Pathol 1990;160:223-30.
44. 44 Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
45. 45 Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156-8.
46. 46 McGuinness PH, Bishop GA, Lien A, et al. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993;18: 485-90.
47. 47 Bishop GA, Rokahr KL, Lowes M, et al. Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method. Immunol Cell Biol 1997;75:142-7.
48. 48 Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
49. 49 Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-90.
50. 50 Fukuda R, Ishimura N, Ishihara S, et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 1996;16: 390-9.
51. 51 Gaweco AS, Rustgi VK, Mitchell B, et al. Concordant type 1 cytokine mRNA and protein expression in chronic HCV-infected livers is associated with the transcription of the novel IFN-γ inducing factor (IL-18) gene [abstract]. Hepatology 1997;26:409A.
52. 52 Shields PL, Salmon M, Hubscher SG, et al. Chemokine-chemokine receptor interactions provide a mechanism for the selective recruitment of Th1 lymphocytes into hepatitis C infected liver [abstract]. Hepatology 1998;28:465A.
53. 53 Ruco LP, Pulford KA, Mason DY, et al. Expression of macrophage-associated antigens in tissues involved by Langerhans cell histiocytosis (histiocytosis X). Am J Clin Pathol 1989;92:273-9.
54. 54 Warnke R, Pulford K, Pallesen G, et al. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol 1989;135:1089-95.
55. 55 Brandtzaeg P, Dale I, Gabrielsen TO. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker and putative biological function. Histopathology 1992;21:191-6.
56. 56 Narumi S, Tominaga Y, Tamaru M, et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 1997;158:5536-44.
57. 57 Taub DD, Lloyd AR, Conlon K, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993;177:1809-14.
58. 58 Bernuau D, Rogier E, Feldmann G. A quantitative ultrastructural analysis of the leukocytes in contact with hepatocytes in chronic active hepatitis, with a cytochemical detection of mononuclear phagocytes. Am J Pathol 1982;109:310-20.
59. 59 Dinarello CA. Interleukin 1 and interleukin 1 antagonism. Blood 1991;77:1627-52.
60. 60 Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-16.
61. 61 Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
62. 62 Tarocco RP, Fenoglio LM, Falbo V, et al. IL-6 receptor expression on hepatocytes in HCV infection [abstract]. Gastroenterology 1997;112:A1397.
63. 63 Hellerbrand C, Jobin C, Iimuro Y, et al. Inhibition of NF-kappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology 1998;27:1285-95.
64. 64 Bishop G, Rokahr K, Napoli J, et al. Intragraft cytokine mRNA levels in human allograft rejection analysed by the reverse transcription and semiquantitative polymerase chain reaction (PCR) amplification. Transplant Immunol 1993;1:253-61.
65. 65 Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-9.